Hardan I - Search Results

1

Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.

Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E, Dor J. Meirow D, et al. Among authors: hardan i. N Engl J Med. 2005 Jul 21;353(3):318-21. doi: 10.1056/NEJMc055237. Epub 2005 Jun 27. N Engl J Med. 2005. PMID: 15983020 No abstract available.

2

Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth.

Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Yemini Z, Dor J. Meirow D, et al. Among authors: hardan i. Fertil Steril. 2007 Feb;87(2):418.e7-418.e15. doi: 10.1016/j.fertnstert.2006.05.086. Epub 2006 Nov 13. Fertil Steril. 2007. PMID: 17097653 Free article.

3

Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience.

Meirow D, Baum M, Yaron R, Levron J, Hardan I, Schiff E, Nagler A, Yehuda DB, Raanani H, Hourvitz A, Dor J. Meirow D, et al. Among authors: hardan i. Leuk Lymphoma. 2007 Aug;48(8):1569-76. doi: 10.1080/10428190701471957. Leuk Lymphoma. 2007. PMID: 17701589

4

Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.

Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, Slyusarevsky E, Amariglio N, Schiff E, Rechavi G, Nagler A, Ben Yehuda D. Meirow D, et al. Among authors: hardan i. Hum Reprod. 2008 May;23(5):1007-13. doi: 10.1093/humrep/den055. Epub 2008 Mar 15. Hum Reprod. 2008. PMID: 18344563

5

Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.

Shimoni A, Hardan I, Shem-Tov N, Rand A, Yerushalmi R, Nagler A. Shimoni A, et al. Among authors: hardan i. Leuk Lymphoma. 2007 Dec;48(12):2352-9. doi: 10.1080/10428190701671051. Leuk Lymphoma. 2007. PMID: 18067010

6

Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization.

Cohen N, Novikov I, Hardan I, Esa A, Brok-Simoni F, Amariglio N, Rechavi G, Ben-Bassat I, Trakhtenbrot L. Cohen N, et al. Among authors: hardan i. Cancer Genet Cytogenet. 2000 Dec;123(2):102-8. doi: 10.1016/s0165-4608(00)00315-0. Cancer Genet Cytogenet. 2000. PMID: 11150599

7

Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis.

Cohen N, Rozenfeld-Granot G, Hardan I, Brok-Simoni F, Amariglio N, Rechavi G, Trakhtenbrot L. Cohen N, et al. Among authors: hardan i. Cancer Genet Cytogenet. 2001 Jul 15;128(2):114-9. doi: 10.1016/s0165-4608(01)00412-5. Cancer Genet Cytogenet. 2001. PMID: 11463449

8

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias.

Shimoni A, Kröger N, Zander AR, Rowe JM, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: hardan i. Leukemia. 2003 Feb;17(2):290-7. doi: 10.1038/sj.leu.2402808. Leukemia. 2003. PMID: 12592325 Clinical Trial.

9

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.

Shimoni A, Kröger N, Zabelina T, Ayuk F, Hardan I, Yeshurun M, Shem-Tov N, Avigdor A, Ben-Bassat I, Zander AR, Nagler A. Shimoni A, et al. Among authors: hardan i. Leukemia. 2005 Jan;19(1):7-12. doi: 10.1038/sj.leu.2403591. Leukemia. 2005. PMID: 15526016

10

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan.

Shimoni A, Hardan I, Shem-Tov N, Rand A, Herscovici C, Yerushalmi R, Nagler A. Shimoni A, et al. Among authors: hardan i. Leukemia. 2007 Oct;21(10):2109-16. doi: 10.1038/sj.leu.2404886. Epub 2007 Aug 9. Leukemia. 2007. PMID: 17690701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters